PHASE 2
Clinical trials for PHASE 2 explained in plain language.
Never miss a new study
Get alerted when new PHASE 2 trials appear
Sign up with your email to follow new studies for PHASE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to halt rare, aggressive cancers
Disease control Not yet recruitingThis study aims to see if a combination of two drugs, zanzalintinib and pembrolizumab, can help control the growth of certain advanced or spreading soft-tissue sarcomas. It will enroll about 20 adults with specific sarcoma subtypes who have not had certain prior treatments. The m…
Matched conditions: PHASE 2
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Radiation 'Priming' tested to supercharge cancer drug
Disease control Not yet recruitingThis study is testing whether giving low doses of radiation therapy before a new drug called elranatamab can help the drug work better against a hard-to-treat form of multiple myeloma. It will involve about 34 adults whose cancer has returned or stopped responding to standard tre…
Matched conditions: PHASE 2
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC